Aphria stock price. Aphria Inc. Stock Price (APHA)

APHA:Toronto Stock Quote

Aphria stock price

In that release, the company. It's also one of the largest in terms of funded production capacity, with a figure of over 500,000 kg. The company is moving fast in expanding its licensed grow space. Source: FactSet Data are provided 'as is' for informational purposes only and are not intended for trading purposes. The company doesn't provide any cannabis products, but it has a major exposure to the industry and is betting big on its growth. At the beginning of October, Goldleaf received a cultivation license from Health Canada.

Next

APH Stock Quote

Aphria stock price

The drug is also being tested for its potential in treating cystic fibrosis, systemic lupus erythematosus, and some other illnesses. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. All retail staff at the Ontario Stores have been temporarily laid-off as the Company awaits further updates from the Province. Its principal drug candidate is called lenabasum, and it is an oral, cannabinoid receptor type 2 agonist formed to help with chronic inflammation and fibrotic processes. But if so, that impact was delayed. Overview page represent trading in all U. Would be crazy to see it at those levels but you never know.

Next

Aphria Inc. (APHA) Stock Historical Prices & Data

Aphria stock price

Similar to its peers, Cronos has been ramping up its production capacity and expects to grow over 47,000 kilograms in early 2019. Many of the staff who were temporarily laid-off from the Ontario Stores are being recalled to fulfill the newly permitted customer orders available to be placed online and by phone. Fundamental company data and analyst estimates provided by FactSet. I'd like to own it at some point. Its products include Capsules, Oral solutions, and Vaporizers.

Next

Aphria Inc. (APHA) Stock Historical Prices & Data

Aphria stock price

Good News Since At the end of January, Aphria closed with an unnamed investor. Given the federal uncertainty that still surrounds cannabis in America and in most of the world, few cannabis companies choose the path of a public listing in order to raise funds and even fewer among them are pure-play marijuana stocks. It operates eight licensed production facilities, with five sales licenses and operations in 18 countries. Sources: CoinDesk Bitcoin , Kraken all other cryptocurrencies Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. That beat the FactSet consensus for a loss per share of 4 cents. Aphria joins a relatively small club of public cannabis companies.

Next

An Irrational Drop in Aphria Stock Presents a Compelling Bullish Case

Aphria stock price

The company developed its own proprietary, reduced-nicotine tobacco varieties ending up with a tobacco product that looks, smokes and tastes like a usual cigarette but contains 95% less nicotine. The company manages a portfolio of real estate properties that it leases to medical cannabis companies in the U. It started the year with around 800,000 square feet, but recently it has said it reached a licensed platform of 4. Its core focus in on four therapeutic fields - oncology, neurosciences, virology, and immunology. CannTrust provides medical and recreational cannabis and cannabis products, operating a 450,000 square-foot facility in Pelham Ontario, which it plans to expand by another 390,000 square feet.

Next

Aphria Inc (APHA

Aphria stock price

This is an oral full agonist of the cannabinoid receptor 2 that is being researched for the treatment of various symptoms, mainly concentrated on visceral pain connected with gastrointestinal illnesses. Aurora was up 7%, Cronos rose 6%, Tilray was up 7%, Aphria was up 8% and Organigram was up 6%. In that kind of environment, some level of selling in Aphria stock is to be expected. Aphria has a much more modest risk but investors have been sprinting away even faster. It is focused on producing and selling medical marijuana and its derivatives through retail sales and wholesale channels.

Next

Aphria Inc. (APHA) Stock Historical Prices & Data

Aphria stock price

Did Earnings Undercut Aphria Stock? Other Funding Sources Cannabis companies are typically able to raise money from venture capital firms, or they can list their stock. It has been investing in expansion and aims to have over 900,000 square feet of production capacity by the end of the year. Furthermore, the company has plans to establish itself as a vertically integrated leader in the U. The company's operations are based in Leamington, Ontario. Financial Market Data powered by QuoteMedia. In January, Pyxus's subsidiary Canadian Cultivated Products acquired 75 percent of Canada's Island Garden and 80 percent of Goldleaf Pharm.

Next

APHA Stock Price and Chart — NYSE:APHA — TradingView

Aphria stock price

. It manufactures and sells fresh produce from its large greenhouses located in Texas and British Columbia and its partner greenhouses in British Columbia, Mexico, and Ontario. FactSet a does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and b shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. In the first part of the list, we focused on pure-play stocks: companies for which cannabis is their core business. The province to lift that ban shortly. Source: FactSet Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays.

Next